Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma

National Institutes of Health: National Heart Lung and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Report no. NIH-NHLI 95-3659. Bethesda (MD): National Institutes of Health National Heart and Lung Institute; 1995

National Institutes of Health: National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Expert panel report II: guidelines for the diagnosis and management of asthma. Report no. NIH-NHLI 97-4051. Bethesda (MD): National Institutes of Health National Heart and Lung Institute; 1997

National Institutes of Health: National Heart Lung and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. Report no. NIH-NHLI 02-3659. Bethesda (MD): National Institutes of Health National Heart and Lung Institute; 2002

Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219–24

Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481–8

Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405–11

Kips JC, O’Connor BJ, Inman MD, et al. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000; 161: 996–1001

Zetterström O, Buhl R, Mellem H, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001; 18: 262–8

Lalloo UG, Malolepszy J, Kozma D, et al. Symbicort® (budesonide and formoterol in a single inhaler) is more effective than increasing the dose of inhaled corticosteroids in mild asthma [abstract]. Am J Respir Crit Care Med 2001; 163: A863

Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405–11

O’Byrne PM, Barnes PJ, Rodriguez-Roison R, et al. Low dose inhaled budesonide with and without formoterol in steroid free patients with mild persistent asthma [abstract]. Am J Respir Crit Care Med 2001; 163: A862

Coutts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67: 332–3

Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–4

Aziz l, Wilson AM, Lipworth BJ. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest 2000; 118: 1049–58

Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report of the working party standardization of lung function tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society. Eur Respir J 1993; 6 Suppl. 16: 5–40

National Institutes of Health: National Heart Lung and Blood Institute. Global initiative for asthma: Pocket Guide for asthma management and prevention. Report no. NIH-NHLI 96-3659B. Bethesda (MD): National Institutes of Health National Heart and Lung Institute; 1998

Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000; 105(6 Pt 1): 1108–16

Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50μg and fluticasone propionate 250μg in the Diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000; 161: 527–34

Jenkins C, Woolcock AJ, Saarelainen P, et al. Salmeterol/fluticasone propionate combination therapy 50/250 twice daily is more effective than budesonide 800μg twice daily in treating moderate to severe asthma. Respir Med 2000; 94: 715–23

Johansson G, Mclvor RA, D’Ambrosio FP, et al. Comparison of salmeterol/fluticasone propionate combination with budesonide in patients with mild-to-moderate asthma. Clin Drug Invest 2001; 21: 633–42

Dahl R, Lundback B, Malo J-L, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993; 104: 1352–8

Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler® is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998; 101: 457–63